Paperpal Prime Logo

Thrombosis Journal : Impact Factor & More

eISSN: 1477-9560pISSN: 1477-9560
JournalOpen Access

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q2Hematology
SNIP
1.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Thrombosis Journal

Thrombosis Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 1990
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Thrombosis Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Thrombosis Journal

Integrating pulmonary embolism response teams: perspectives and outcomes from a European and German survey analysis
  • 4 Aug 2026
  • Thrombosis Journal
Thrombosis in rare bleeding disorders: a bleeding phenotype does not fully preclude thrombotic risk- frequency, clinical contexts, and management in a large Iranian cohort
  • 29 Jul 2026
  • Thrombosis Journal
Prevalence of obstructive sleep apnea syndrome in patients with pulmonary embolism: a prospective observational study.
  • 18 Jul 2026
  • Thrombosis journal
Timing of disseminated intravascular coagulation onset is associated with development of persistent inflammation, immunosuppression, and catabolism syndrome in critically ill patients.
  • 15 Jul 2026
  • Thrombosis journal
Urinary 11-dehydrothromboxane B2 as a dynamic biomarker of atherosclerotic thrombotic risk and its association with plaque instability.
  • 14 Jul 2026
  • Thrombosis journal
The PH score: a practical tool for screening myeloproliferative neoplasms in acute portal vein thrombosis.
  • 3 Jul 2026
  • Thrombosis journal
Integrating pulmonary embolism response teams: perspectives and outcomes from a European and German survey analysis
  • 4 Aug 2026
  • Thrombosis Journal
Thrombosis in rare bleeding disorders: a bleeding phenotype does not fully preclude thrombotic risk- frequency, clinical contexts, and management in a large Iranian cohort
  • 29 Jul 2026
  • Thrombosis Journal
Prevalence of obstructive sleep apnea syndrome in patients with pulmonary embolism: a prospective observational study.
  • 18 Jul 2026
  • Thrombosis journal
Timing of disseminated intravascular coagulation onset is associated with development of persistent inflammation, immunosuppression, and catabolism syndrome in critically ill patients.
  • 15 Jul 2026
  • Thrombosis journal
Urinary 11-dehydrothromboxane B2 as a dynamic biomarker of atherosclerotic thrombotic risk and its association with plaque instability.
  • 14 Jul 2026
  • Thrombosis journal
The PH score: a practical tool for screening myeloproliferative neoplasms in acute portal vein thrombosis.
  • 3 Jul 2026
  • Thrombosis journal

FAQs on Thrombosis Journal